* You are viewing the archive for October, 2010

CRE to FDA/TPSAC: Allow Public Comment on Peer Review Plans for Menthol as Statutorily Required

The FDA has released   material its October  meeting.

The FDA material references initiation and cessation studies. The overwhelming number of these studies were reviewed in detail by the  CRE DQA petition.

 Should not the CRE DQA petition be reviewed by TPSAC as part of its review of the studies identified by FDA?

Is the TPSAC going  to  submit  a  report  which complies with the DQA or is going to ignore the statute and send a report which the FDA can not use?

What is the role of the non-voting tobacco representatives in the preparation of the report?